PBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Pitney Bowes is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has improved materially and the pre-market setup is constructive, but the current price is already near resistance and the recent rally has likely priced in much of the turnaround. I would not call it a strong new buy at this level; hold off unless you already own it and want to maintain exposure.
PBI is in an overall bullish short-term trend, with SMA_5 above SMA_20 above SMA_200, which supports upward momentum. However, MACD histogram is slightly negative and contracting, suggesting momentum is not fully confirmed. RSI_6 at 67.4 is elevated but not overbought. The pre-market price of 16.74 is very close to R1 at 16.842, so upside from here looks limited in the near term unless it breaks resistance cleanly. Pivot support sits at 16.08, with deeper support at 15.32. Overall trend is positive, but entry at current levels is not especially attractive for a patient long-term investor.
["Citizens raised its price target to $19 from $17 and kept an Outperform rating.", "BofA upgraded the stock to Neutral from Underperform after better-than-expected Q1 results.", "Truist and Goldman Sachs both raised price targets, reflecting improving operating visibility.", "News flow points to improving revenue stabilization in SendTech and stronger cost controls.", "The company extended the maturity of its term loan, which supports financing flexibility.", "The Postal Service proposed changes to presorted mail economics that may help Pitney Bowes' competitive positioning.", "Share buybacks and debt repurchases continue to support per-share value."]
["CEO Kurt Wolf sold 243,938 shares under a 10b5-1 plan, which still adds to near-term selling pressure.", "Hedge funds are selling, with selling increasing 713.33% over the last quarter.", "Insiders are selling, with selling increasing 1209.72% over the last month.", "The company is still dealing with revenue decline, even if the pace is improving.", "The stock has already had a strong year-to-date run, so expectations are higher now.", "The current price is near overhead resistance, limiting immediate upside."]
The latest quarter shown in analyst commentary is Q1 2026. Q1 revenue declined 3% year over year, but that was an improvement from the prior quarter. SendTech showed stronger performance, and Presort benefited from improved sales execution and retention. Operating margins expanded significantly due to cost controls, and the 2026 outlook was modestly raised with a smaller expected revenue decline and less margin pressure. This points to a business that is stabilizing, but not yet in a strong growth phase.
Recent analyst trends are improving. Citizens, BofA, Goldman Sachs, and Truist all lifted price targets in May and early June 2026. Citizu200bens remains bullish with an Outperform rating and a $19 target, while BofA moved to Neutral with a $16.50 target, suggesting the easy upside may be partly priced in. Goldman and Truist are also constructive but less aggressive. Overall Wall Street sentiment is positive-to-neutral: the pros see turnaround progress, margin expansion, and better capital returns, but several believe the stock has already moved up enough to reflect much of the good news.
